When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE ...

James Choate-Deeds always stayed on top of his health. So when the dad of three turned 50, he wanted to get screened for prostate cancer. It's done through a PSA test, which measures the amount of ...

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery James Choate-Deeds was diagnosed with prostate cancer when he was 57 He connected ...

He connected with Dr. James Porter, Chief Medical Officer for Robotic and Digital Technologies at Medtronic, who suggested Choate-Deeds join a clinical trial for Hugo, a robotic-assisted surgery ...

Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Some foods and drinks can worsen prostate health. Saturated fats ...

Thirty-eight years ago, I was initiated into the oldest and one of the largest Black fraternities in the world: Alpha Phi Alpha Fraternity, Inc. It was one of the happiest days of my life. In ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to ...

More than 70% of patients with biochemically recurrent prostate cancer remained metastasis-free 5 years after PSMA PET/CT-guided salvage radiation therapy. Whole-pelvis radiation significantly ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...

CLEVELAND — The FDA has reversed course and announced it will now review Moderna's mRNA flu vaccine application after initially declining to accept it earlier this month. The agency had raised ...